We have examined the histopathological factors affecting the degree of local spread, regional lymph node (RLN) However, specific patient subsets (G1, node negative) may exhibit an excellent survival when curative pancreas resection is successful.
INTRODUCTION
Pancreas cancer is the fourth most common cause of cancer related mortality in the United States12, with an overall survival rate of 0-5%. Despite advances in diagnostic technology, most patients are identified by clinical presentation, and associated local and distant spread25. Even in patients wtih localized disease, mean survival remains less than 16 months after attempted curative resection3'67. Surgical resection, however, remains the only chance for long term survival3'67.
Certain pathological characteristics of the pancreatic cancer seem to be important in predicting outcome81. The degree of local spread of the primary tumor and status of the regional lymph nodes have been recognized as important determinants of staging by the American Joint Committee on Cancerv2. By understanding how nodal involvement, subsets of patients may be identified that would be more amenable to attempted curative resection.
We retrospectively reviewed pathological data from resected cases of pancreatic cancer with particular attention to the extent of loco-regional invasion, histopathological characteristics of the primary tumor, lymphatic invasion, size, and, differen comparing size and degree of local spread were stratified for location of the primary tumor, the degree of local spread remained similar to the group as a whole (data not shown). Therefore, it seems that size, as a predictor of local spread, is similar for different regions of the pancreas. Table 4 analyzes the relationship of histological grade and degree of local spread. Sixteen tumors were well differentiated neoplasms as compared to 21 tumors with moderately to poorly differentiated histology. The degree of differentiation was a significant factor in predicting which tumors were limited to the pancreas. 31% of the well differentiated tumors were T1 lesions whereas only 14% of the less well differentiated group were contained within the pancreas (p < .05). In contract, the T2 lesions demonstrated histologies that were more undifferentiated in 67% of the specimens (p < .005). Patients with T3 local spread were equally as likely to have well differentiated versus less well differentiated tumors. Although the well differentiated tumors were equally distributed among the different types of local spread (T1, Y2, T3), the less well differentiated pancreatic carcinomas were more often seen with peripancreatic spread. Regional Lymph Node Involvement Of the thirty-seven patients resected for cure, pathologic data for metastatic regional lymph node involvement was available on 35 patients (Table 7) . Sixteen patients (45%) were free of nodal involvement and 19 patients (55%) had at least one positive lymph node. We had previously demonstrated that the degree of local spread could influence survival following curative resection (Table 6 , Figure 1 ). We next examined whether this effect was due to the status of regional lymph nodes.
As shown in As seen in Table 9 , the degree of differentiation of the primary tumor was a significant determinant of nodal status in the well differentiated group. As previously stated, only G1 tumors were different when examined for regional lymph node involvement (63% versus 37% respectively). The Survival as a function of regional lymph node status was next examined. As demonstrated in Table 10 the overall survival for patients with negative lymph nodes was 23.5 months. This is in contrast to the overall survival for patients with positive lymph nodes which was 7.4 months (p < .05). Figure 2 demonstrates the overall survival for node negative and node positive patients at 36 months. 31% of the node negative pancreatic cancer patients were alive at 36 months. This is in sharp contrast to 5% of patients alive with positive lymph nodes. The survival by nodal status was further stratified by size and histologic grade (Table 11 ). There remained a significant difference for mean survival between node negative and node positive patients for tumors -< 4 and tumors greater than 4 cm.
The combination of differentiation and nodal status demonstrated differences in survival for node negative patients. For patients with negative regional lymph nodes, well differentiated status predicted for improved survival when compared to less well differentiated status (32.5 months versus 14.4 months, respectively p < .05). In contrast, the finding of positive lymph nodes was more important than differentiation status for survival. There was no difference in survival between well differentiated and less well differentiated positive node patients. In summary, there remained a significant difference in overall survival between node negative patients and node positive patients in all groups. Most importantly, a subset of patients with well differentiated tumors and regional lymph nodes free of disease demonstrated the longest survival in this series of 32.5 months from the time of resection. This differed from a subset of patients with less well differentiated, node free disease who had a mean survival of 14.4 months from resection. No stratification of node positive patients predicted for improved survival within this poor prognosis group of patients. predictors of improved surgical outcome3'7'z9. Some of these include improved technical aspects for the performance of pancreatectomy as well as regionalization and specialization for major pancreatic resection. The results of our study predict that this improvement should be interpreted within the context of clearly defined histopathological parameters of the tumor that may influence long term survival. In our series, both the degree of local spread and regional lymph node metastases had a significant effect on survival after operation.
We have shown a median overall survival for the entire group of resected cancer patients of 14.3 months and actuarial survival of 17.6% at 36 months. These results seem to compare favorably with other large series of reported cases of resectable carcinoma of the pancreas6"2122. This survival is the result of a number of complex factors the most important of which is the biological aggressiveness of the tumor as measured by the pathological stage.
Other recognized important factors include delay to presentation, perioperative mortality, and other more recently recognized independent prognostic factors such as blood transfusions67'17'22-23. We have shown, however, that with careful subset analysis, groups may exist that exhibit satisfactory long term results. For example we have shown that tumors confined to the pancreas exhibit from 1 1/2 to 4 fold increase in the median overall survival when compared to locally infiltrating or regionally advanced pancreas cancer (see Table 10 ). More importantly the absence of regional lymph nodes confers a three-fold increased survival advantage over node positive patients, with the median overall survival for patients with negative lymph nodes approximating 21 months (see Figure 2) It has been previously recognized that most early carcinomas of the pancreas are located in the pancreatic head12'24. In our series, 88% of the T tumors were small tumors located in the head of the pancreas. However, 2/3 of these small pancreatic head lesions are associated with metastatic carcinoma. Furthermore, although the chance for a tumor to be localized (T) is greater in lesions in the head than for other regions, only the minority of the resected pancreatic head carcinomas in our series were limited to the pancreas at the time of operation.
Similarly, when examining T2 lesions, small tumor size (< 4cm) did not accurately predict confined local spread or nodal status. Large tumors > 4 cm as a group were characterized by a greater degree of local spread and regional lymph node involvement. This frequent spread of small tumors is reflected by the absence of increased survival for small tumors compared to large tumors when one stratifies the patients by similar nodal status.
The degree of histologic differentiation seems to favorably effect the degree of local spread of the primary in our series. Patients with well differentiated tumors were also more likely to be free of lymph node metastases. generally carry higher rates of resectability and better survival4-6, possibly because they are diagnosed at an earlier stage or are less biologically aggressive.
This histological characteristics of the resection specimen have also been the object of study. Malignant infiltration of the pancreatic capsule, proximity of the tumour to lymphatic or blood vessels, round cell infiltration at the tumour margin and epithelial atypia in the pancreatic ducts away from the tumour are all factors that have been associated with a poor prognosis7. The location of a tumour in the pancreatic body and tail or an eccentric site within the head (far from the duct) are also unfavourable factors8. To obtain these data, endoscopic ultrasonography can make a valuable contribution to preoperative staging9, supplementing conventional abdominal ultrasound and CT Scan. Another crucial factor in determining the outcome is the presence of tumour-free margins in the resected part1'11.
Regional lymph node involvement has received a good deal of attention. As Brower and colleagues report, lymph node metastasis usually conveys a very poor prognosis3 '12-14 
